Articles in refereed journals
Dandash O, …, Russell N,..., Kanaan RA (2024). The effect of estradiol add-back: a longitudinal MRI study in prostate cancer patients. Endocrine Connections (online ahead of print): DOI: 10.1530/EC-23-0409.
Warren AM, Grossmann M, Christ-Crain M, Russell N (2023). Syndrome of inappropriate antidiuresis: from pathophysiolgy to management. Endocr Rev (online ahead of print): DOI: 10.1210/endrev/bnad010.
Russell N, Hoermann R, Cheung AS, Zajac JD, Grossmann M (2022). Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial. Eur J Endocrinol 187 (5):617-627. DOI: 10.1530/EJE-22-0318.
Zanker J, Sim M, …, Russell N,..., Daly RM, Scott D (2022). Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. J Cachexia Sarcopenia Muscle (accepted). DOI: 10.1002/jcsm.13115.
Russell N, Ghasem-Zadeh A, Hoermann R, Cheung AS, Zajac JD, Shore-Lotenti C, Ebeling PR, Handelsman DJ, Grossmann M (2022). Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial. Eur J Endocrinol 187 (2): 241-256. DOI: 10.1530/EJE-22-0227.
Warren AM, Grossmann M, Hoermann R, Zajac JD, Russell N (2022). Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): Design and implementation of an open-label randomised trial. Trials 23 (1): 335. DOI 10.1186/s13063-022-06237-5.
Russell N, Allebone J, Dandash O, Hoermann R, Cheung AS, Zajac JD, Handelsman DJ, Kanaan RA, Grossmann M (2022). Effect of estradiol on cognition in men undergoing androgen deprivation therapy: a randomized trial. Clin Endocrinol (Oxf) (Online ahead of print). DOI: 10.1111/cen.14689.
Russell N, Hoermann R, Cheung AS, Zajac JD, Handelsman DJ, Grossmann M (2021). Effects of estradiol on fat mass in men undergoing androgen deprivation therapy: a randomized trial. Eur J Endocrinol 186 (1): 9-23. DOI: 10.1530/EJE-21-0663.
Ramchand SK, Russell N, Grossmann M (2021). Optimising bone health during endocrine therapy for hormone sensitive cancer. Endocrinology Today 10 (4). 14-18.
Russell N, Grossmann M (2021). Management of bone and metabolic effects of androgen deprivation therapy. Urol Oncol 39 (10): 704-712. DOI.org/10.1016/j.urolonc.2018.10.007.
Nolan BJ, Brownhill A, Bretherton I, Wong P, Fox S, Locke P, Russell N, Grossmann M, Zajac JD, Cheung A (2020). Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy. Ther Adv Endocrinol (11). DOI: 10.1177/2042018820924543.
Atallah P, Kanaan R, Russell N, Allebone R, Grossmann M (2020). Cognitive function in prostate cancer patients on androgen deprivation therapy: A case-control study. Gen Hosp Psychiatry 67: 152-153. DOI: 10.1017/j.genhosppsych.2020.04.005.
Russell N, Grossmann M (2019). Mechanisms in Endocrinology: Estradiol as a male hormone. Eur J Endocrinol 181 (1): R23-R43. DOI: 10.1530/EJE-18-1000.
Russell N, Hoermann R, Cheung A, Ching M, Zajac JD, Handelsman DJ, Grossmann M (2018). Short-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. Eur J Endocrinol 178 (5): 565-576. DOI: 10.1530/EJE-17-1072.
Russell N, Cheung A, Grossmann M (2017). Estradiol for the mitigation of adverse effects of androgen deprivation therapy. Endocr Relat Cancer 24 (8):R297-R313. DOI: 10.1530/ERC-17-0153.
Russell N, O’Brien RC (2016). Diabetes and Hypertension: Is treatment of hyperglycaemia useful? Dialog Cardiovasc Med 21 (2): 136-146.
Russell NDF, Cooper ME (2015). 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications. Diabetologia 58 (8): 1708-1714. DOI: 10.1007/s00125-015-3600-1.
Russell N, Delatycki M, Grossmann M (2015). Metastatic phaeochromocytoma in a 23-year-old woman with an unclassified variant in the von Hippel Lindau disease gene: How can the pathogenicity of this variant be determined? Clin Endocrinol 83 (1): 15-19. DOI: 10.1111/cen.12710.
Hanssen NM, Russell N, Cooper ME (2015). Recent advances in glucose-lowering treatment to reduce diabetic kidney disease. Expert Opin Pharmaco 16 (9): 1325-1333. DOI: 10.1517/14656566.2015.1041502.
Editorials & letters in refereed journals
Wang R, Colman PG, Kyi M, Russell N, Fourlanos S (2021). Longitudinal prevalence of inpatient diabetes mellitus in an Australian hospital across five decades: 1972-2019. Intern Med J 51: 814-815. DOI: 10.1111/imj.15322
Russell N (2019). End-of-life care in hospital. Intern Med J 49 (8): 1056. DOI: 10.1111/imj.14385
Russell N, Grossmann M (2016). Plasma miRNA expression profile in the diagnosis of late-onset hypogonadism. Asian J Androl 18 (5): 713-715. DOI: 10.4103/1008-682X.182819
Russell N, Stevenson AD (2015). Colonoscopy in young women. Intern Med J 45 (11): 1198. DOI: 10.1111/imj.12852.
Book chapters
Zajac JD, Seeman E, Russell N, Ramchand SK, Bretherton I, Grossmann M, Davey R (2020). Chapter: Testosterone. Book: Reference Module in Biomedical Sciences. Elsevier. DOI.org/10.1016/B978-0-12-801238-3.11263-2.
Revised and updated ‘Male Androgen Deficiency’ chapter in Therapeutic Guidelines Sexual and Reproductive Health Version 6. Therapeutic Guidelines 2020.
Revised and updated ‘Low Libido in Males’ chapter in Therapeutic Guidelines Sexual and Reproductive Health Version 6. Therapeutic Guidelines 2020.
Revised and updated ‘Erectile Dysfunction’ chapter in Therapeutic Guidelines Sexual and Reproductive Health Version 6. Therapeutic Guidelines 2020.
Invited conference presentations
Russell N (2023). Hormone Dependent Cancers Symposium: Estradiol for men undergoing androgen deprivation therapy for prostate cancer. ESA-SRB Annual Scientific Meeting, 26-29 Nov 2023.
Russell N (2021). ESA live webinar: Inpatient hyponatraemia: why it matters and how to manage it in 2021. RACP Congress, 29 Apr - 14 May 2021.
Russell N (2021). Symposium presentation: Estradiol in men with metabolic disorders. 19th International Congress of Endocrinology, ICE Virtual 2021, 24-28 Feb 2021.
Russell N (2020). Inpatient hyponatraemia: beyond fluid restriction. Proceedings of the sixty-third annual conference of the Endocrine Society of Australia, ESA Virtual, 31 Oct-1 Nov 2020.
Russell N (2019). Hyponatraemia - update for general physicians. Proceedings of the annual scientific meeting of the Internal Medicine Society of Australia and New Zealand, Melbourne Australia 5-7 Sept 2019.
Conference abstracts
Russell N (2023). Effects of estradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial. ESA-SRB Annual Scientific Meeting, 26-29 Nov 2023.
Russell N, Hoermann R, Ghasem-Zadeh A, Cheung AS, Zajac JD, Handelsman DJ, Grossmann M (2021). Effects of estradiol on bone density and fat mass in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. ESA-SRB-ANZBMS 2021, 21-24 November 2021. Abstract 140.
Russell N, Allebone J, Dhandash O, Hoermann R, Cheung AS, Zajac JD, Handelsman DJ, Kannan RA, Grossmann M (2021). Effects of estradiol on cognition in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. ESA-SRB-ANZBMS 2021, 21-24 November 2021. Abstract 194.
Zanker J, Sim M, …, Russell N, …, Daly R, Scott D (2021). The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force: Findings from the consumer Delphi Process. Australasian Journal on Ageing 40 (1): 55-56.
Zanker J, Sim M, …, Russell N, …, Daly R, Scott D (2021). The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force: Findings from the expert Delphi Process. Australasian Journal on Ageing 40 (1): 56-57.
Nolan BJ, Brownhill A, …, Russell N, …, Zajac J, Cheung A (2020). Estradiol dose and concentrations in transfeminine individuals. J Endocr Soc 4 (Suppl 1) . Abstract ID: SUN-039. DOI 10.1210/jendso/bvaa046.877.
Wang R, Kyi M, …, Russell N, …, Johnson D, Fourlanos S (2019). Diabetes and acute impaired glycaemia affects two thirds of inpatients: point-prevalence study in a tertiary hospital. Proceedings of the annual scientific meeting of the Australasian Diabetes Congress, Sydney Australia 21-33 August 2019. Abstract ID: 243.
Russell N, Delatycki M, Grossmann M (2014). Case report: a 23-year-old woman with malignant phaeochromocytoma. Proceedings of the Endocrine Society of Australia Clinical Weekend, Torquay Australia 22-24 August 2014. Abstract ID: 006.
Russell N, Varadarajan S (2013). A young man with refractory acromegaly. Proceedings of the fifty-sixth annual conference of the Endocrine Society of Australia, Sydney Australia 25-28 August 2013. Abstract ID: 354.
Russell N, Russell D, Nanayakkara N, Seymour C, Colman PG, Fourlanos S (2012). Doubling of diabetes prevalence in hospital inpatients from 1996-2012. Proceedings of the annual scientific meeting of the Australian Diabetes Society and Australian Diabetes Educators Association, Gold Coast Australia 29-31 August 2012. Abstract ID: 304.
Non-refereed articles
Russell N, Grossmann M (2016). Not a benign condition (Hyponatraemia therapy update part 2). Australian Doctor 5 August 2016: 31-35.
Russell N, Grossmann M (2016). Water balance (Hyponatraemia therapy update part 1). Australian Doctor 29 July 2016: 31-34.
Russell N, Cooper ME (2015). Type 2 diabetes management in Australia: where are we and where are we headed? Diabetes Management Journal 2: 4-5.